期刊
CELL CHEMICAL BIOLOGY
卷 23, 期 1, 页码 122-136出版社
CELL PRESS
DOI: 10.1016/j.chembiol.2015.12.003
关键词
-
资金
- NIH grant [R01 EB005011]
- Stanford Medical Scientist Training Program
- National Science Foundation Graduate Research Fellowship grant [DGE-114747]
The Precision Medicine Initiative aims to use advances in basic and clinical research to develop therapeutics that selectively target and kill cancer cells. Under the same doctrine of precision medicine, there is an equally important need to visualize these diseased cells to enable diagnosis, facilitate surgical resection, and monitor therapeutic response. Therefore, there is a great opportunity for chemists to develop chemically tractable probes that can image cancer in vivo. This review focuses on recent advances in the development of optical probes, as well as their current and future applications in the clinical management of cancer. The progress in probe development described here suggests that optical imaging is an important and rapidly developing field of study that encourages continued collaboration among chemists, biologists, and clinicians to further refine these tools for interventional surgical imaging, as well as for diagnostic and therapeutic applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据